Here are the 10-K annual reports from 22nd Century Group Inc. (XXII) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow XXII and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full XXII filings page.
22nd Century Group, Inc. files its annual report describing a niche tobacco business built around VLN® reduced-nicotine cigarettes, the only combustible products with FDA Modified Risk Tobacco Product orders. The company leases a North Carolina factory capable of producing more than 45 million cartons annually and also does contract manufacturing.
Management discloses a long history of losses, negative cash flow and “substantial doubt” about its ability to continue as a going concern, with approximately $3.8 million of cash and cash equivalents as of March 20, 2026. It depends heavily on raising additional capital, and warns it may need to liquidate assets, curtail operations or seek bankruptcy protection if funding is unavailable.
The report highlights significant regulatory and competitive risk: operations rely on FDA marketing and MRTP orders for its very low nicotine cigarettes, with current exposure‑modification authority expiring in December 2026 and an extension request submitted in 2025. As of June 30, 2025, aggregate market value of common stock was about $3.5 million, with 662,023 shares outstanding on March 20, 2026 and only 32 employees, underscoring the company’s small scale, Nasdaq listing vulnerability and potential dilution from outstanding warrants and convertible preferred shares.